Terbinafine HCl 250 mg Tablet Under Fasting Conditions

Mise à jour : Il y a 4 ans
Référence : NCT00833586

Femme et Homme

Extrait

The purpose of this study is to evaluate the relative bioavailability of the test formulation of terbinafine tablets with an already marketed reference formulation Lamisil® (Novartis Pharmaceuticals), under fasted conditions in healthy, non-tobacco using male and female adult subjects.


Critère d'inclusion

  • Healthy

Liens